U.S. PhRMA Sees Hope In India PM Modi's Visit To Address IPR Problems
This article was originally published in PharmAsia News
Executive Summary
U.S. drug makers have high hopes a new prime minister of India will be able to use his first official visit to America in September to resolve disputes over pharmaceutical intellectual property rights.